Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021
- DOI
- 10.1001/jamahealthforum.2022.1096
- Published
- 2022-05-20
- Container
- JAMA Health Forum
- Publisher
- American Medical Association (AMA)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1001/jamahealthforum.2022.1096,
title = {Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021},
author = {Ravi Gupta and Christopher J. Morten and Angela Y. Zhu and Reshma Ramachandran and Nilay D. Shah and Joseph S. Ross},
year = {2022},
journal = {JAMA Health Forum},
doi = {10.1001/jamahealthforum.2022.1096},
url = {https://doi.org/10.1001/jamahealthforum.2022.1096}
}RIS
TY - JOUR TI - Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021 AU - Ravi Gupta AU - Christopher J. Morten AU - Angela Y. Zhu AU - Reshma Ramachandran AU - Nilay D. Shah AU - Joseph S. Ross PY - 2022 JO - JAMA Health Forum DO - 10.1001/jamahealthforum.2022.1096 UR - https://doi.org/10.1001/jamahealthforum.2022.1096 ER -
APA
Gupta, R., Morten, C. J., Zhu, A. Y., Ramachandran, R., Shah, N. D., & Ross, J. S. (2022). Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021. JAMA Health Forum. https://doi.org/10.1001/jamahealthforum.2022.1096
Source records
- crossref · retrieved 2026-09-27T11:07:44.872Z